Eric Lancaster Selected Research

Isaacs Syndrome (Neuromyotonia)

7/2022	Autoantibody Encephalitis: Presentation, Diagnosis, and Management.
1/2018	Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.
9/2014	Paraneoplastic disorders in thymoma patients.
10/2013	Acquired neuromyotonia heralding recurrent thymoma in myasthenia gravis.
2/2011	Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia.
8/2010	Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Lancaster Research Topics

Disease

12	Encephalitis (Encephalitis, Rasmussen) 07/2022 - 01/2010
7	Seizures (Absence Seizure) 07/2022 - 01/2010
7	Neoplasms (Cancer) 01/2020 - 01/2010
6	Isaacs Syndrome (Neuromyotonia) 07/2022 - 08/2010
5	Glioma (Gliomas) 12/2017 - 08/2010
4	Autoimmune Diseases of the Nervous System 01/2018 - 01/2010
4	Stiff-Person Syndrome (Stiff Man Syndrome) 12/2017 - 01/2013
4	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2017 - 01/2010
3	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 04/2015
3	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2019 - 04/2015
3	Myasthenia Gravis 12/2017 - 10/2013
3	Brain Diseases (Brain Disorder) 01/2017 - 08/2010
2	Dyskinesias (Dyskinesia) 07/2022 - 11/2019
2	Cerebellar Diseases (Cerebellar Syndrome) 01/2021 - 01/2017
2	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2021 - 12/2017
2	Epilepsy (Aura) 08/2020 - 02/2015
2	Coma (Comas) 11/2019 - 06/2012
2	Nervous System Paraneoplastic Syndromes 01/2019 - 12/2017
2	Hodgkin Disease (Hodgkin's Disease) 01/2017 - 08/2014
2	Progressive Encephalomyelitis with Rigidity 01/2016 - 01/2013
2	Myoclonus (Nocturnal Myoclonus) 01/2016 - 01/2013
1	Spasm (Spasms) 07/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Temporal Lobe Epilepsy 08/2020
1	Partial Epilepsies (Epilepsy, Partial) 08/2020
1	Cognitive Dysfunction 11/2019
1	Multiple Myeloma 01/2019
1	Hypertrophy 01/2019
1	Movement Disorders (Movement Disorder) 01/2019
1	Necrosis 01/2019
1	Frontotemporal Dementia (Semantic Dementia) 01/2019
1	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2019
1	Central Nervous System Vasculitis 01/2019
1	Hypoventilation 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2019
1	Disease Progression 01/2019
1	Crohn Disease (Crohn's Disease) 09/2018
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 09/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018
1	Multiple Sclerosis 01/2018
1	Polyneuropathies (Polyneuropathy) 01/2018
1	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 01/2018
1	Guillain-Barre Syndrome 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Psychotic Disorders (Schizoaffective Disorder) 01/2017
1	Lymphoma (Lymphomas) 08/2015
1	Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease) 08/2015
1	Nervous System Diseases (Neurological Disorders) 02/2015
1	Cerebellar Ataxia (Dysmetria) 02/2015
1	Thymoma (Thymic Carcinoma) 09/2014
1	Paraneoplastic Cerebellar Degeneration 08/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013

Drug/Important Bio-Agent (IBA)

19	AntibodiesIBA 08/2020 - 01/2010
12	AutoantibodiesIBA 07/2022 - 01/2010
11	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2010
6	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2020 - 01/2010
6	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2019 - 01/2011
5	Leucine (L-Leucine)FDA Link 12/2017 - 08/2010
4	AntigensIBA 12/2017 - 01/2010
4	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2014 - 08/2010
4	AutoantigensIBA 06/2012 - 08/2010
3	Membrane Proteins (Integral Membrane Proteins)IBA 12/2017 - 07/2011
3	Aminobutyrates (Aminobutyric Acid)IBA 11/2017 - 06/2012
2	NivolumabIBA 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2016
2	N-Methylaspartate (NMDA)IBA 01/2019 - 12/2017
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2019 - 01/2018
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 08/2014
2	Immunoglobulin G (IgG)IBA 01/2018 - 01/2013
2	AcidsIBA 11/2017 - 06/2012
1	Pharmaceutical PreparationsIBA 08/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	ProgranulinsIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2019
1	B-Cell Maturation AntigenIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	Adalimumab (Humira)FDA Link 09/2018
1	Cell Adhesion MoleculesIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2018
1	Cytidine DeaminaseIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Homer Scaffolding Proteins (Homer 1)IBA 01/2017
1	metabotropic glutamate receptor type 1IBA 01/2017
1	Metabotropic Glutamate 5 ReceptorIBA 01/2017
1	N 30IBA 08/2015
1	Cholinergic ReceptorsIBA 09/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2014
1	Epidermal Growth Factor (EGF)IBA 08/2014

Therapy/Procedure

9	Immunotherapy 01/2020 - 01/2010
5	Therapeutics 01/2019 - 01/2016
1	Treatment Delay 01/2019
1	Aftercare (After-Treatment) 01/2016
1	Plasma Exchange 02/2015
1	Drug Therapy (Chemotherapy) 08/2014
1	Thymectomy 10/2013